Supply of equipment, reagents and related services for neonatal screening for galactosemia and biotinidase deficiency

Summary

Resah is procuring equipment, reagents and related services for neonatal screening for galactosemia and biotinidase deficiency under a single-supplier framework agreement divided into two lots. Lot 1 provides a complete screening solution for facilities with low or medium activity volumes, and Lot 2 provides a complete solution for high-volume facilities. The estimated value is €3 million per lot, with a maximum framework value of €12 million per lot.